CEDARS-SINAI MEDICAL CENTER

🇺🇸United States
Ownership
Private, Subsidiary
Established
1902-01-01
Employees
12K
Market Cap
-
Website
http://www.cedars-sinai.org

Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)

First Posted Date
2010-03-12
Last Posted Date
2011-12-12
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
4
Registration Number
NCT01085643
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

Tadalafil in Becker Muscular Dystrophy

Phase 4
Completed
Conditions
Interventions
First Posted Date
2010-02-18
Last Posted Date
2013-08-20
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
48
Registration Number
NCT01070511
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

Cedars Sinai Medical Center, Los Angeles, California, United States

The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function

First Posted Date
2009-09-09
Last Posted Date
2012-02-07
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
6
Registration Number
NCT00973557
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

Cortisol Levels on Menopausal Symptoms - Ancillary (Addendum) Study to Protocol 16997

Completed
Conditions
Interventions
First Posted Date
2009-08-03
Last Posted Date
2019-06-07
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
45
Registration Number
NCT00950781
Locations
🇺🇸

Cedars-Sinai Women's Heart Center, Los Angeles, California, United States

Pilot Study - Impact of Traditional Acupuncture on Menopause

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2009-07-31
Last Posted Date
2019-04-10
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
45
Registration Number
NCT00950482
Locations
🇺🇸

Cedars-Sinai Women's Heart Center, Los Angeles, California, United States

Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy

Phase 2
Completed
Conditions
Interventions
First Posted Date
2009-07-15
Last Posted Date
2020-01-22
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
9
Registration Number
NCT00939523
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Early Identification of Subclinical Atherosclerosis Using Non-Invasive Imaging Research (EISNER)

First Posted Date
2009-06-25
Last Posted Date
2011-09-29
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
2137
Registration Number
NCT00927693
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly

Active, not recruiting
Conditions
Interventions
First Posted Date
2009-06-16
Last Posted Date
2024-04-23
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
20
Registration Number
NCT00921609
Locations
🇺🇸

Cedars-Sinai Medical Center, Pituitary Center, Los Angeles, California, United States

Lanreotide Levels in Acromegaly

Conditions
Interventions
First Posted Date
2009-06-10
Last Posted Date
2009-06-10
Lead Sponsor
Cedars-Sinai Medical Center
Registration Number
NCT00916916
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)

First Posted Date
2009-06-08
Last Posted Date
2019-07-09
Lead Sponsor
Cedars-Sinai Medical Center
Target Recruit Count
28
Registration Number
NCT00915954
Locations
🇺🇸

Cedars-Sinai Medical Center Pituitary Center, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath